Research programme: next-generation HIV gp120 vaccines - VaxGen
Latest Information Update: 19 Sep 2006
At a glance
- Originator VaxGen
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 19 Sep 2006 Discontinued - Preclinical for HIV infections prevention in USA (unspecified route)
- 12 Jun 2003 Preclinical trials in HIV infections prevention in USA (unspecified route)